Avalon Acquisition Inc. (NASDAQ:AVAC) has secured shareholder approval for its combination with financial services firm Beneficient with about 87% of shares redeemed at the final vote.
The redemptions removed all but $27.9 million from Avalon’s trust, but the transaction did not include a minimum cash condition beyond the $5 million required for listing purposes. Avalon also added a $25 million forward-purchase agreement with RiverNorth SPAC Arbitrage Fund earlier this week, which was designed to scoop up some shares headed for redemption.
This led to the seventh-lowest redemption rate among the 33 SPACs that have made it through completion votes in 2023. Only $5 million of the FPA amount is to be distributed to Beneficient at close, however.
Beneficient shares and warrants are expected to begin trading on the Nasdaq today under the symbols “BENF” and “BENFW”, but the company’s Series A preferred stock is to remain unlisted.
The SPAC originally inked its $3.5 billion deal with Ben in September 2022. The Dallas-based company provides customers options to exit alternative investments early via structures designed for high-net-worth individuals and small institutions.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...